SWOG clinical trial number
SWOG-8404
Evaluation of Esorubicin in Pancreatic Adenocarcinoma
Closed
Phase
Published
Abbreviated Title
Evaluation of Esorubicin in Pancreatic Adenocarcinoma
Activated
08/17/1984
Closed
10/01/1986
Publication Information Expand/Collapse
1990
Phase II evaluation of esorubicin (4' deoxydoxorubicin) in pancreatic adenocarcinoma. A Southwest Oncology Group study.